MiMedx Group, Inc. reported a 45% drop in Q3 2026 net sales to $62 million due to a 71% decline in wound care sales, impacted by Medicare reimbursement changes. However, surgical product sales grew 9%, driving mid-teens volume growth in the surgical franchise which now accounts for nearly two-thirds of net sales. The company returned to positive Adjusted EBITDA and improved its GAAP net loss sequentially, reflecting cost reductions and operational efficiencies. MiMedx also secured a favorable court ruling on AXIOFILL's regulatory classification and entered a $25 million patent license agreement, while preparing for the acquisition of Sanara MedTech pending regulatory approval.
MiMedx Group's Q3 2026 results provide context for health sector activity. For readers following health stocks, 103 of 150 US health-sector stocks on Pluang rose, 46 fell as of Oct 29, 2026 03:21 WIB. Notable movers include AXGN at USD 48.98 (+30.75%, 37% Sell / 63% Buy), DNA at USD 13.33 (+18.28%, 45% Sell / 55% Buy), and NUWE at USD 6.25 (+17.26%, 74% Sell / 26% Buy).
SpaceX reported a strong Q3 with revenue up 161% year-over-year to $14.6 billion and a net profit of $4.4 billion, reversing last year's loss. Starlink, its satellite internet service, grew revenue by nearly 70% to $5.2 billion and added 1.6 million ...
SPIE, a leading European multi-technical services provider, has signed an agreement to acquire a 76% stake in SAR ANLAGENBAU GmbH, a major electrical engineering and automation firm based in Austria and Germany. This acquisition will enhance SPIE's p...
SPIE, a European leader in energy and communication services, has agreed to acquire a 76% stake in SAR ANLAGENBAU GmbH, a key electrical engineering and automation firm in Austria and Germany. This acquisition will broaden SPIE's service portfolio in...
The global dermatological therapeutics market is projected to grow from about $43 billion in 2025 to $97 billion by 2034, with a compound annual growth rate of around 10%. This growth is fueled by increasing cases of acne, psoriasis, and other chroni...
Blockchain.com has launched TRX options trading, providing easier access to TRON's native token through its platform. This move expands the TRON ecosystem's reach by simplifying options trading for retail and institutional users worldwide. TRON, know...
